Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants

PLOS Global Public Health(2023)10.1371/journal.pgph.0002037Source: DataRank Database

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants is a research paper published in PLOS Global Public Health (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.90)OA: goldTopics (14)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Xue Han ORCID,Shannon Grant ORCID,Esther Kwara,Bharathi Lakshminarayanan,Michael Stirewalt

Live enrichment

PubMed:37289667 PMC:PMC10249892 OpenAlex:https://openalex.org/W4379966303

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068614

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068618

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068635

Center for AIDS Research, Duke University

Grant: P30 AI064518

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI069412

National Center for Research Resources

Grant: UL1 RR025758

FWCI

0.90

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pgph.0002037

publisherhttps://doi.org/10.1371/journal.pgph.0002037

publisherhttps://dx.plos.org/10.1371/journal.pgph.0002037

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37289667

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10249892

Fields of Study

HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Keywords

DurabilityProtocol (science)Human immunodeficiency virus (HIV)MedicineHIV vaccineImmunologyVirologyVaccine trialAlternative medicineComputer sciencePathology

Sustainable Development Goals

SDG 0: Good health and well-being